Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) II: In Vitro In Vivo Correlations (IVIVC)
-
Add time:08/26/2019 Source:sciencedirect.com
A dependable in vitro in vivo correlation (IVIVC) is a vital tool to optimize drug formulation and expedite product development time. Although many IVIVC examples are available for oral delivery systems, IVIVC for transdermal delivery is far less common, especially for electrical-assisted delivery. The objective of this study was to develop an IVIVC for the iontophoretic delivery of the anticancer drug etoposide. Iontophoresis was performed at 4 current densities (100, 200, 300, and 400 μA/cm2) both in vitro using a standard Franz-cell apparatus with excised porcine skin as membrane, and in vivo in a rabbit model. There was strong correlation between the in vitro % permeated across porcine skin and in vivo absorption (AUC, Cmax) in the range 100-300 μA/cm2. The correlation between in vitro flux and in vivo input rate (R0) permitted to predict the R0 from a different set of in vitro data (external validation). Convolution of such input rate accurately predicted in vivo plasma profiles (PE% <15) in the absorption phase, whereas the elimination phase was slightly under-predicted (PE% >20). In vivo absorption profiles obtained with deconvolution did not overlap directly with the in vitro profiles; however, correction for the lag time and the application of a scaling factor estimated from Levy' s plots resulted in excellent correlation.
We also recommend Trading Suppliers and Manufacturers of Etoposide phosphate (cas 117091-64-2). Pls Click Website Link as below: cas 117091-64-2 suppliers
Prev:Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) I: In Vitro and In Vivo Evaluation
Next:In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationDetermination of Etoposide phosphate (cas 117091-64-2) intermediates by gradient liquid chromatography using postcolumn derivatization with cuprammonium hydroxide09/03/2019
- Micronization of etoposide using solution-enhanced dispersion by supercritical CO209/02/2019
- RESEARCHPhysical and Chemical Stability of Etoposide phosphate (cas 117091-64-2) Solutions09/01/2019
- Short communicationPhase I and pharmacokinetic study of a water-soluble etoposide prodrug, Etoposide phosphate (cas 117091-64-2) (BMY-40481)08/31/2019
- In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment08/30/2019
- Etoposide phosphate (cas 117091-64-2) or etoposide with cisplatin in the treatment of small cell lung cancer: Randomized Phase II trial08/29/2019
- Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study08/28/2019
- In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin08/27/2019
- Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) I: In Vitro and In Vivo Evaluation08/25/2019


